MDxHealth SA (MDXH)
(Delayed Data from NSDQ)
$3.16 USD
+0.33 (11.66%)
Updated Aug 16, 2024 04:00 PM ET
After-Market: $3.18 +0.02 (0.63%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MDXH 3.16 +0.33(11.66%)
Will MDXH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MDXH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MDXH
Agiliti (AGTI) Q4 Earnings Beat Estimates
DermTech, Inc. (DMTK) Reports Q4 Loss, Misses Revenue Estimates
MDXH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Viatris (VTRS) Beats Q3 Earnings Estimates
Surgery Partners (SGRY) Soars 9.9%: Is Further Upside Left in the Stock?
Pediatrix Medical Group (MD) Lags Q3 Earnings and Revenue Estimates
Other News for MDXH
MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21
MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance
Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors
MDxHealth files to sell 2.24M shares for holders
MDxHealth files to sell 2.24M ordinary shares for holders